# Adjuncts for Adductor Block: Dexamethasone,Dexmedetomidine, or Combination to Reduce Pain

> **NCT03643822** · NA · TERMINATED · sponsor: **Women's College Hospital** · enrollment: 3 (actual)

## Conditions studied

- ACL Injury

## Interventions

- **DRUG:** Dexamethasone 4mg
- **DRUG:** Dexmedetomidine
- **OTHER:** Saline

## Key facts

- **NCT ID:** NCT03643822
- **Lead sponsor:** Women's College Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2020-02-21
- **Primary completion:** 2026-04-16
- **Final completion:** 2026-04-16
- **Target enrollment:** 3 (ACTUAL)
- **Why stopped:** Since study conception and approval in 2018, we have shown that the analgesic benefit of an adductor canal block is not clinically significant in the setting of ACL reconstruction surgery of the knee.
- **Last updated:** 2026-04-23

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03643822

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03643822, "Adjuncts for Adductor Block: Dexamethasone,Dexmedetomidine, or Combination to Reduce Pain". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03643822. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*